IPW
BLUE

Impact Partnership Wealth’s bluebird bio BLUE Stock Holding History

Impact Partnership Wealth’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8
Closed -$549 – 1028
2023
Q2 		$549 Buy
+8
New +$585 ﹤0.01% 855

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Impact Partnership Wealth's BLUE Position: Q3 2023 in Review

Impact Partnership Wealth sold out of bluebird bio (BLUE) in Q3 2023, closing a stake of 8 shares — an estimated $549 sold.

Impact Partnership Wealth first reported a position in BLUE in Q2 2023 and held it in 1 quarter. The position peaked at $549 in Q2 2023. 168 funds tracked by Wall St. Rank hold BLUE as of Q3 2023.

  • Impact Partnership Wealth reported no remaining bluebird bio position as of Q3 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 8 bluebird bio shares in Q3 2023, an estimated $549.
  • Impact Partnership Wealth first reported a position in bluebird bio in Q2 2023 and held it in 1 quarter.
  • Impact Partnership Wealth's bluebird bio position peaked at $549 in Q2 2023.
  • 168 funds tracked by Wall St. Rank held bluebird bio as of Q3 2023.

Based on Impact Partnership Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.